The Acme Group began its journey in 2005 with a bold mission of becoming a leader in the contract manufacturing space and a preferred business partner for pharmaceutical companies seeking world-class capabilities and scalable operations.

Guided by the founder's vision and purpose, the Acme Group has scaled new heights in the pharmaceutical value chain over the years. Today, it provides fully integrated contract manufacturing and development solutions to some of the top Indian and global pharmaceutical companies.

Acme is driven by a belief in fast growth combined with a focus on innovation and service. The group currently consists of three state-of-the-art, fast-growing companies: Acme Formulation, Immacule Lifesciences, and Acme Generics.

Powering the group are 2500+ highly skilled staff across over 1 million sq. ft. of manufacturing space in Northern India, producing 17 billion tablets, 3 billion capsules, 30 million Liquid vials/ampoules and 12 million Lyophilized vials annually. Our expertise lies in the niche segments of oral hormones, including female sex hormones and levothyroxine, along with liquid and lyophilized injectables We are also expanding our sterile manufacturing capacity to produce an additional 60 million general liquid and lyophilized vials, 60 million liquid and lyophilized vials for oncology, 30 million three-piece ophthalmic containers, and 24 million pre-filled syringes and cartridges annually.

Over the past decade, we have been audited and approved by various international regulatory agencies, including USFDA, UK-MHRA, EU-GMP, Health Canada, TGA Australia, ANVISA, INVIMA, and WHO Geneva. In addition, we have received approvals across major emerging markets in Asia, Africa, CIS, and Latin America. With 22 ANDAs approved, 18 ANDAs filed and under review, and a target of 50+ ANDA approvals by 2025, we continue our journey towards building a sustainable future as a leading CDMO.

Our Vision & Mission

VISION
   - To become a globally reputed company in supply of high quality innovative oral solid and sterile drug products.

MISSION
   - To develop, register & commercialize maximum generic oral solid and sterile drug products across all regulated and emerging markets.

Acme looks to the future with ever higher goals and ambitions and with its unwavering focus on service and quality is strategically poised to grow even further in the years ahead.